BioSpace News Archive

Policy

Department of Defense Awards Novavax $60 Million COVID-19 Vaccine Contract

“We are genuinely honored at the opportunity to protect our military personnel and their families who have devoted themselves to the needs of U.S. citizens and others worldwide,” said Stanley C. Erck, president and chief executive officer of Novavax.

June 5, 2020
·
4 min read
·
Mark Terry
BIO Annual Meeting Goes Digital with Focus on COVID-19

This year’s event, which kicks off June 8, will have a different look as an entirely digital conference.

June 5, 2020
·
2 min read
·
Alex Keown
Drug Development

AstraZeneca Commits to 2 Billion Doses of COVID-19 Vaccine, Potentially by End of Year

UK-based AstraZeneca and the University of Oxford have partnered on the global development and distribution of Oxford’s COVID-19 vaccine, AZD1222.

June 5, 2020
·
3 min read
·
Mark Terry
Genetown

Investment Group Atlas Venture Closes $400 Million Fund for Biotech Startups

With the close of the fund, Atlas Venture said it will continue to advance its mission of “doing well by doing good” and building biotech companies that will deliver high-impact therapies to patients.

June 5, 2020
·
2 min read
·
Alex Keown
Policy

Inovio Files Complaint to Break Ties With CMO Over COVID-19 Vaccine Production Issues

Inovio’s development issues for its vaccine candidate have become mired in a conflict with the contract manufacturing organization it has worked with on previous projects.

June 5, 2020
·
2 min read
·
Alex Keown
Policy

Biopharma Update on the Novel Coronavirus: June 5

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.

June 5, 2020
·
3 min read
·
BioSpace Editorial Staff
Business

Daiichi Sankyo, Syneos Health Eye New Cancer Therapies with Collaboration Agreement

Daiichi Sankyo announced on May 28 that it had entered an agreement with Syneos Health to form a coalition dedicated to bringing new cancer therapies to patients in a safe and effective manner.

June 5, 2020
·
3 min read
·
Krystle Vermes
Policy

FDA Action Alert: Viela, Merck, Epizyme, Evoke and Regeneron

The next two weeks are busy ones for the U.S. Food and Drug Administration (FDA). Here’s a look at PDUFA dates for this period.

June 5, 2020
·
4 min read
·
Mark Terry
BioForest

Clinical Catch-Up: May 31-June 5

As summer begins, we’re seeing a shift away from COVID-19-related news and a stronger output of other clinical trial news. Here’s a look.

June 5, 2020
·
10 min read
·
Mark Terry
Healios Successfully Establishes Proprietary Universal Donor Cell Research Line

Healios K.K., Japan’s leading clinical-stage biotechnology company, has been creating Universal Donor Cells, which are next-generation iPS cells created with gene-editing technology to engineer a low risk of immune rejection regardless of HLA types.

June 5, 2020
·
3 min read